Targeting BRCA2 deficiency with GSK3 inhibitors
<p>BRCA1 and BRCA2 tumour suppressors are essential for homologous recombination-mediated double-strand break repair and replication fork protection. Therefore, BRCA1 and BRCA2 are essential for cell viability. Deactivating mutations in one of these genes lead to genome instability and are ass...
1. Verfasser: | Zonderland, G |
---|---|
Weitere Verfasser: | Tarsounas, M |
Format: | Abschlussarbeit |
Veröffentlicht: |
2017
|
Ähnliche Einträge
Ähnliche Einträge
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
von: Tacconi, E, et al.
Veröffentlicht: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
von: Eliana MC Tacconi, et al.
Veröffentlicht: (2019-05-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
von: Zimmer, J, et al.
Veröffentlicht: (2016) -
Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
von: Ashwin Ragupathi, et al.
Veröffentlicht: (2023-03-01) -
Novel approaches for targeting BRCA2-deficient tumour cells
von: Tacconi, E
Veröffentlicht: (2015)